Ki-67, marker of proliferation
Guinebretière, J.M.; Sabourin, J.C.
Annales de Pathologie 17(1): 25-30
1997
ISSN/ISBN: 0242-6498 PMID: 9162153 Document Number: 483840
Document emailed within 1 workday
Related Documents
Hansen, J.T.; Benghuzzi, H.; Tucci, M.; Cason, Z. 2003: The role of black seed in the proliferation and biochemical marker levels of Hep-2 cells Biomedical Sciences Instrumentation 39: 371-376Gerdes, J.; Pileri, S.; Bartels, H.; Stein, H. 1986: Proliferation marker Ki-67: correlation with histological diagnosis, neoplasm grading and clinical course Verhandlungen der Deutschen Gesellschaft für Pathologie 70: 152-158
Vitali, C.; Ferri, C.; Nasti, P.; La Civita, L.; Mazzantini, M.; Longombardo, G.; Bombardieri, S. 1994: Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia British Journal of Rheumatology 33(8): 791-792
Vitolo, B.; Lidonnici, M.R.; Montecucco, C.; Montecucco, A. 2005: A new monoclonal antibody against DNA ligase I is a suitable marker of cell proliferation in cultured cell and tissue section samples European Journal of Histochemistry: Ejh 49(4): 349-354
Kanabrocki, E.L.; Ryan, M.D.; Murray, D.; Jacobs, R.W.; Wang, J.; Hurder, A.; Friedman, N.C.; Siegel, G.; Eladasari, B.; Nemchausky, B.A.; Cornelissen, G.; Halberg, F. 2006: Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. a potential cancer marker? La Clinica Terapeutica 157(2): 117-122
Abra, R.M.; Schreier, H.; Szoka, F.C. 1982: The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker Research Communications in Chemical Pathology and Pharmacology 37(2): 199-213
Hsu, L.F.; Koh, T.H.; Lim, Y.L. 2000: Cardiac marker point-of-care testing: evaluation of rapid on-site biochemical marker analysis for diagnosis of acute myocardial infarction Annals of the Academy of Medicine Singapore 29(4): 421-427
Ghizzi, A.; Gorini, M.; Ascari, E. 1985: "in vitro" growth acceleration of CFU-GM proliferation: a new criterion of measure of proliferation features of granulocytic progenitor cells Haematologica 70(6): 482-486
Russell, J.H.; Manning, D.E.; McCulley, D.E.; Meleedy-Rey, P. 1988: Antigen as a positive and negative regulator of proliferation in cytotoxic lymphocytes. A model for the differential regulation of proliferation and lytic activity Journal of Immunology 140(6): 1796-1801
Niermeiier, P.; Gips, C.H.; Huizenga, J.R.; Ringers, J.; Verkerk, S.; Houthuff, H.J.; Houwen, B.; Snijder, J.A.; Nielsen, J.O. 1978: IgM-anti-HBc as a marker of persistent and IgG-anti-HBc as a marker of past hepatitis B infection. a longitudinal study over 5 years Acta Hepato-Gastroenterologica 25(5): 360-364
Komori, T.; Habuchi, Y.; Inoue, H.; Sakai, T.; Suzuki, K.; Ohtsuka, K.; Tanaka, H.; Fujita, N.; Yoshimura, M. 1997: Application of urinary free dopamine as a marker of renal function, and comparison with other renal marker Rinsho Byori. Japanese Journal of Clinical Pathology 45(7): 679-684
Yagita, H.; Hashimoto, Y. 1986: Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes Journal of Immunology 136(6): 2062-2068
Leggieri, C.; D'Agostino, G.; Tommasi, L.; Plebani, M.; Conte, L. 2014: Is HE4 a useful endometrioma marker? European Journal of Gynaecological Oncology 35(4): 438-441
Pabst, T.; Ludwig, C. 1995: CA 125--a tumor marker? Schweizerische Medizinische Wochenschrift 125(24): 1195-1200
Cerná, A.; Cuadrado, A.; Jouve, N.; Díaz de la Espina, S.M.; De la Torre, C. 2004: Z-DNA, a new in situ marker for transcription European Journal of Histochemistry: Ejh 48(1): 49-56
Kobayashi, M.; Kiyosawa, K. 2010: HGV related viral marker Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 462-464
Lugo-Somolinos, A.íd.; Sánchez, J.E. 2003: Xanthomas: a marker for hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(4): 12-16
Okochi, M.; Tagami, S.; Yanagida, K.; Takeda, M. 2010: Surrogate marker for ABeta42 Nihon Shinkei Seishin Yakurigaku Zasshi 30(4): 169-172
Lust, G.; Burton-Wurster, N.; Leipold, H. 1987: Fibronectin as a marker for osteoarthritis Journal of Rheumatology 14(Special Issue): 28-29
Bhatia, V.; Mathew, B. 2003: QRS widening as a marker of dys-synchrony Indian Heart Journal 55(3): 281; Author Reply 282